Nature Communications (Jul 2021)
Artificial intelligence guided discovery of a barrier-protective therapy in inflammatory bowel disease
Abstract
Traditional drug discovery process use differential, Bayesian and other network based approaches. We developed a Boolean approach for building disease maps and prioritizing pre-clinical models to discover a first-in-class therapy to restore and protect the leaky gut barrier in inflammatory bowel disease.